CRT 2026

Panel Discussion

Moderator(s)

• 

  Lawrence Biegelsen, MBA

  Managing Director Medical Supplies & Devices
  Wells Fargo
  Short Hills, New Jersey, United States

  Disclosure information not submitted.
• 

  Rick Wise, CFA

  Research Analyst
  Stifel
  New York, New York, United States

  Disclosure information not submitted.

Panel Discussant(s)

• 

  Dominic Allocco, MD, MS

  Associate Chief Medical Officer
  Shockwave/Johnson & Johnson, Minnesota, United States

  Disclosure information not submitted.
• 

  Daniel Burkhoff, MD, PhD

  Director: Heart Failure, Hemodynamics and MCS Research
  Cardiovascular Research Foundation
  New York, New York, United States

  Disclosure information not submitted.
• 

  Megan Coylewright, MD, MPH

  Structural interventional cardiologist
  Essentia Health, Minnesota, United States

  Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Alleviant Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Navin K. Kapur, MD, FSCAI FAHA FACC

  Professor of Medicine
  Tufts Medical Center
  Boston, Massachusetts, United States

  Disclosure information not submitted.
• 

  Dean J. Kereiakes, MD, FACC, MSCAI

  Chairman, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University
  The Christ Hospital Health Network
  Cincinnati, Ohio, United States

  Disclosure information not submitted.
• 

  Gregg W. Stone, MD, FACC, MSCAI

  Physician
  Mount Sinai
  New York, New York, United States

  Disclosure(s): Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter, Vascentis: Stock-privately held company (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Consulting Fees (e.g., advisory boards) (Terminated); Colibri, Remote Cardiac Enablement, Valfix, Zoll, HeartFlow, Shockwave, Ancora, Adona Medical, Abbott, HighLife, Elucid Bio, Aria, Alleviant, FBR Medical, Bioventrix, MedHub, Biotyx Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave, Biosense-Webster, Bioventrix, Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Pulnovo, V-wave and PCORI via Weill Cornell Medical Center.: Grant/Research Support (Ongoing)